IntrinsicIntrinsic
← All summaries

Arrive AI Inc.

ARAI
Financials & Chart →

Business Summary

Arrive AI Inc. is an early-stage technology company focused on designing and implementing a commercially viable smart mailbox and platform system for the secure and seamless exchange of packages, goods, supplies, food, and medications using robots and drones . The company began commercial operations in 2025, having generated no revenues in prior fiscal years . Arrive AI aims to build a universal Autonomous Last Mile (ALM) network of "Arrive Points" which are smart lockers and mini-cross-docks, serving as secure, asynchronous exchange points connecting various delivery systems and stakeholders . The company believes its platform provides the "Highest Common Denominator" infrastructure to support and accelerate innovation across the automated last-mile industry, serving medical, pharmaceutical, retail, e-commerce, and logistics sectors .

The company's core business model revolves around three primary revenue streams: the Arrive Point Network (Network-as-a-Service), AI Services, and the ALM Marketplace . The Network-as-a-Service model provides secure, asynchronous delivery and pickup points with features like temperature assistance and secure chain of custody, offered through monthly and annual subscription fees, along with installation, support, maintenance, and infrastructure services . AI Services leverage machine learning (ML) and artificial intelligence (AI) to monetize transactional and environmental data, providing insights such as reverse logistics optimization, routing density, and growth forecasting . The ALM Marketplace is a software platform designed for dynamic pricing, management of "gate times," and optimization of high-demand space across the Arrive Point network, facilitating functions like arrival/departure scheduling and smart notifications .

Arrive AI's product and service lines include multi-generational Arrive Points (AP3, AP4, and upcoming AP5) that are being developed for universal compatibility with major drone and robotic delivery systems . These units offer robust chain-of-custody security, temperature assistance, and seamless physical-digital synchronization . The AP3 units began revenue operation in 2025 . ML capabilities are primarily deployed in AP4 and AP5 units for local IoT data processing and edge computing, while broader AI capabilities derive insights from network data . Advanced marketplace capabilities are planned for introduction with AP5 units .

For the fiscal year ended December 31, 2025, Arrive AI reported total revenue of $113,250 . The company incurred a net loss of $12,826,384 . Operating expenses totaled $10,465,856 . General and administrative expenses were $9,636,140 , research and development expenses were $600,510 , and sales and marketing expenses were $229,206 . The company had cash and cash equivalents of $2,104,004 as of December 31, 2025. Total liabilities were $8,455,465 , and total stockholders' equity (deficit) was $2,475,600 . Basic and diluted EPS was $(0.40) . Net cash used in operating activities was $8,253,348 . The company had convertible notes payable, net of discount and debt issuance costs, of $4,144,657 .

Comparing 2025 to 2024, revenue increased from $0 in 2024 to $113,250 in 2025, reflecting the start of commercial operations. Net loss increased from $4,537,901 in 2024 to $12,826,384 in 2025. General and administrative expenses increased by $6,089,620 to $9,636,140 in 2025, primarily due to a $5,822,581 increase in salaries and benefits, including $1,866,531 in one-time success bonuses related to the public listing in May 2025. Research and development expenses decreased by $159,526 to $600,510 in 2025, mainly due to a $437,921 decrease in vendor engineering projects, partially offset by higher independent contractor spend of $160,145 and one-time success bonuses of $118,250 . Sales and marketing expenses decreased by $36,976 to $229,206 in 2025, driven by lower television advertising of $100,000 .

Significant operational developments during the period include the installation of third-generation Arrive Points (AP3 units) in the fourth quarter of 2024, which began generating revenue in 2025 . The company secured pilot programs with a regional hospital and a specialty pharmaceutical delivery company . Arrive AI also acquired four fully-issued US patents through the purchase of Airbox assets in 2023 . On September 8, 2025, the Board of Directors authorized a share repurchase program of up to $10,000,000 of its common stock through March 31, 2026 , under which 19,700 shares were repurchased for $74,743 and subsequently retired . The company also entered into a new five-year lease agreement for its headquarters in Fishers, Indiana, with a related party, commencing October 1, 2025 .

Business Outlook

Management's plans to address liquidity needs include utilizing existing cash and cash equivalents of approximately $2.1 million as of December 31, 2025, deploying $9.6 million in net proceeds received from a January 2026 financing with Streeterville Capital, LLC, and potentially drawing additional amounts under the Securities Purchase Agreement with Streeterville, which provides up to an additional $19.0 million in gross borrowings . As of April 10, 2026, the company's cash, cash equivalents, and short-term investments were approximately $8.2 million .

The company's five-year plan targets the deployment of 100,000 Arrive Points , aiming for a revenue model of approximately 50% Network-as-a-Service and 50% Marketplace & AI Services . Revenue is expected to accelerate as installations scale and subscription, marketplace, and AI service models are activated . Key phases include transitioning from early third-generation (AP3) units toward fourth- and fifth-generation (AP4 and AP5) hardware, which will fully enable marketplace transactional economics and advanced AI services . The ALM Marketplace, with advanced capabilities planned for introduction with AP5 units, is expected to drive future revenue through dynamic pricing, management of "gate times," and optimization of high-demand space across the network . AI Services will monetize transactional and environmental data generated by the network, with ML powering edge computing in AP4 and AP5, and broader AI capabilities deriving actionable insights such as reverse logistics optimization and growth forecasting .

The operational outlook includes continued investment in product development, engineering, and marketing activities . The company plans to expand its sales and marketing infrastructure for commercialization, with an initial focus on medical operations such as hospitals, labs, clinics, doctors, pharmacies, and large assisted living businesses, with eventual expansion to other market segments . The company's strategy leverages its intellectual property and technological advantages developed in AP1, AP2, AP3, AP4, and soon AP5, to position its ALM MaaS solutions as the industry standard .

Planned capital allocation includes significant investments in research and development relating to products and services . The company incurred capital expenditures of $495,185 in 2025. Future capital expenditures will depend on growth, customer acquisition, market acceptance, and platform development . The Board of Directors authorized a share repurchase program of up to $10,000,000 of common stock through March 31, 2026 . The company does not anticipate paying any cash dividends on its common stock in the foreseeable future, intending to retain future earnings to fund ongoing operations and capital requirements .

Management has flagged several structural headwinds and execution risks. The recent financings with Streeterville Capital involve pre-paid purchase agreements that may cause significant shareholder dilution and downward pressure on the stock price . Certain triggers, including sustained declines in share price, could accelerate cash repayment obligations that the company may not be able to meet . The company's revenues to date have been derived from a limited number of customers, with more than 90% of total revenue in 2025 coming from a single customer, Hancock Health, indicating customer concentration risk . Global supply chain shortages may impact future plans, potentially leading to higher costs for inventory and non-cancelable purchase commitments, which could introduce inventory risk and delay revenue forecasts .

Geographic, regulatory, and macro factors also pose constraints. The potential for growth depends on continued permission and acceptance by local governments and municipalities of autonomous robot and drone deliveries . Changes in regulations, such as restrictions on autonomous vehicle operation or technical requirements, could reduce or limit revenue generation and impact unit economics . The company is subject to evolving and expanding privacy and data security laws and regulations, including HIPAA for medical facilities, with compliance being costly and any failure potentially resulting in material liability and regulatory penalties . The ongoing conflict between Ukraine and Russia and geopolitical conditions, including instability in the Middle East, could indirectly impact the business by increasing global energy and transportation costs and contributing to higher material and logistics costs .

Risk Factors

The company faces substantial macroeconomic, competitive, regulatory, and operational risks. There is substantial doubt about the company's ability to continue as a going concern due to recurring operating losses and negative cash flows from operations since inception, with cash and cash equivalents of approximately $2.1 million as of December 31, 2025, and an average cash burn rate of approximately $1,000,000 per month. The company is highly dependent on its management team, and the loss of key personnel could materially adversely affect the business. Rapid technological changes in the Smart Mailbox for Automation (SMA) market could render existing infrastructure obsolete, requiring significant capital investments to maintain competitiveness. Competition from other SMA companies, including Matternet and Valqari, and automation efforts by carriers like FedEx and UPS, poses a risk, as many competitors have substantially greater resources. The adoption and commercialization of AI technology are inherently uncertain, and failure to keep up with evolving AI infrastructure requirements or a shortage of AI talent could adversely impact the business. The company's SaaS model exposes it to recurring revenue risks, including customer churn and pricing pressure. Product development is a long, expensive, and uncertain process, and significant failures in quality control systems could harm the business. Physical security breaches at facilities could result in loss of sensitive information. Reliance on third-party open-source and commercial software components carries risks of non-compliance with license terms, potentially restricting product offerings. Failures in internet infrastructure or Wi-Fi access could lead to perceptions of unreliability and customer churn. Cybersecurity threats and data breaches, originating from various actors and methods, could result in operational disruption, data loss, reputational harm, legal liability, and financial losses. The company is subject to evolving privacy and data security laws and regulations, including CCPA, CPRA, and HIPAA, with compliance being costly and non-compliance potentially leading to significant penalties. Operating in highly regulated businesses, including those related to the U.S. Postal Service and FAA regulations for drone and robot deliveries, requires significant resources and is subject to potential new and changing laws. The company is subject to ongoing litigation, including an employment action with alleged damages up to $29 million , which could result in substantial costs and divert management attention. The public trading market for the company's common stock may not continue to be liquid and its price may be volatile, and the company has received notification letters from Nasdaq regarding non-compliance with minimum Market Value of Publicly Held Shares (MVPHS) of $15,000,000 and Market Value of Listed Securities (MVLS) of $50,000,000 requirements, with a deadline of September 28, 2026 to regain compliance. Material weaknesses in internal control over financial reporting have been identified, which could lead to inaccurate or untimely financial reporting. The company's growth and financial health are subject to economic risks such as extreme volatility in securities prices, geopolitical instability, and inflation.

Management Priorities

Management's message to shareholders conveys a tone of cautious optimism regarding the company's pioneering role in the Autonomous Last Mile (ALM) era, while explicitly acknowledging the significant financial and operational challenges inherent in an early-stage commercial company. They emphasize the integrated ALM Platform, combining the physical Arrive Point Network, ALM Marketplace, and AI Services, as the "Highest Common Denominator" infrastructure to accelerate industry innovation. Management has provided specific guidance for its five-year plan, targeting the deployment of 100,000 Arrive Points and achieving a revenue model split of approximately 50% Network-as-a-Service and 50% Marketplace & AI Services . They also highlighted the recent closing of Pre-Paid Purchase No. 4 with Streeterville Capital, LLC on January 26, 2026, which provided $10,000,000 in gross proceeds, and the potential to draw an additional $19.0 million under the Securities Purchase Agreement. The three strategic priorities emphasized for the period ahead appear to be: (1) scaling the deployment of Arrive Points, particularly transitioning to AP4 and AP5 units to enable advanced marketplace and AI services; (2) expanding the customer base beyond the current concentration, with an initial focus on medical operations; and (3) actively monitoring and addressing Nasdaq listing compliance requirements, including the MVPHS of $15,000,000 and MVLS of $50,000,000 by September 28, 2026 .

View Source Annual Report on SEC.gov ↗

References

  1. [1] Item 1, Business — Corporate History
  2. [2] Item 1A, Risk Factors — Risks Related to Our Early-Stage Commercial Operations and Financial Condition
  3. [3] Item 1, Business — Company Overview
  4. [4] Item 1, Business — Company Overview
  5. [5] Item 7, MD&A — Company Overview
  6. [6] Item 7, MD&A — Company Overview
  7. [7] Item 7, MD&A — Company Overview
  8. [8] Item 7, MD&A — Company Overview
  9. [9] Item 1, Business — Company Overview
  10. [10] Item 1, Business — Company Overview
  11. [11] Item 7, MD&A — Company Overview
  12. [12] Item 7, MD&A — Company Overview
  13. [13] Item 7, MD&A — Company Overview
  14. [14] Item 7, MD&A — Results of Operations
  15. [15] Item 7, MD&A — Results of Operations
  16. [16] Item 7, MD&A — Results of Operations
  17. [17] Item 7, MD&A — Results of Operations
  18. [18] Item 7, MD&A — Results of Operations
  19. [19] Item 7, MD&A — Results of Operations
  20. [20] Item 7, MD&A — Liquidity and Capital Resources
  21. [21] Item 8, Balance Sheets
  22. [22] Item 8, Balance Sheets
  23. [23] Item 8, Statements of Operations
  24. [24] Item 7, MD&A — Cash Flow and Liquidity
  25. [25] Item 8, Balance Sheets
  26. [26] Item 7, MD&A — Revenues
  27. [27] Item 7, MD&A — Revenues
  28. [28] Item 7, MD&A — Financial Overview
  29. [29] Item 7, MD&A — Financial Overview
  30. [30] Item 7, MD&A — Operating Expenses
  31. [31] Item 7, MD&A — Operating Expenses
  32. [32] Item 7, MD&A — Operating Expenses
  33. [33] Item 7, MD&A — Operating Expenses
  34. [34] Item 7, MD&A — Operating Expenses
  35. [35] Item 7, MD&A — Operating Expenses
  36. [36] Item 7, MD&A — Operating Expenses
  37. [37] Item 7, MD&A — Operating Expenses
  38. [38] Item 7, MD&A — Operating Expenses
  39. [39] Item 7, MD&A — Operating Expenses
  40. [40] Item 7, MD&A — Operating Expenses
  41. [41] Item 7, MD&A — Operating Expenses
  42. [42] Item 7, MD&A — Company Overview
  43. [43] Item 1, Business — ALM Platform for Industry Innovation
  44. [44] Item 1, Business — Patents
  45. [45] Item 5, Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities
  46. [46] Item 5, Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities
  47. [47] Item 15, Note 15 — Share Repurchase Program
  48. [48] Item 15, Note 15 — Share Repurchase Program
  49. [49] Item 13, Certain Relationships and Related Transactions, and Director Independence
  50. [50] Item 15, Note 4 — Liquidity and Going Concern
  51. [51] Item 15, Note 4 — Liquidity and Going Concern
  52. [52] Item 15, Note 4 — Liquidity and Going Concern
  53. [53] Item 15, Note 4 — Liquidity and Going Concern
  54. [54] Item 15, Note 4 — Liquidity and Going Concern
  55. [55] Item 1, Business — Five-Year Public Plan
  56. [56] Item 1, Business — Five-Year Public Plan
  57. [57] Item 1, Business — Five-Year Public Plan
  58. [58] Item 1, Business — Five-Year Public Plan
  59. [59] Item 7, MD&A — Company Overview
  60. [60] Item 7, MD&A — Company Overview
  61. [61] Item 7, MD&A — Financial Overview
  62. [62] Item 1A, Risk Factors — If our marketing efforts are unsuccessful, we may not generate sufficient revenue to become profitable.
  63. [63] Item 1, Business — Competition
  64. [64] Item 1A, Risk Factors — Product development is a long, expensive and uncertain process.
  65. [65] Item 7, MD&A — Capital Expenditures
  66. [66] Item 7, MD&A — Capital Expenditures
  67. [67] Item 5, Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities
  68. [68] Item 5, Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities
  69. [69] Item 5, Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities
  70. [70] Item 7, MD&A — Outlook And Challenges Facing Our Business
  71. [71] Item 7, MD&A — Outlook And Challenges Facing Our Business
  72. [72] Item 15, Note 19 — Entity-Wide Disclosures
  73. [73] Item 7, MD&A — Outlook And Challenges Facing Our Business
  74. [74] Item 7, MD&A — Outlook And Challenges Facing Our Business
  75. [75] Item 7, MD&A — Outlook And Challenges Facing Our Business
  76. [76] Item 7, MD&A — Outlook And Challenges Facing Our Business
  77. [77] Item 1A, Risk Factors — We will be subject to rapidly changing and increasingly stringent laws, regulations, industry standards, and other obligations relating to privacy, data protection, and data security.
  78. [78] Item 1A, Risk Factors — The ongoing conflict between Ukraine and Russia could adversely affect our business, consolidated financial condition, and results of operations.
  79. [79] Item 1A, Risk Factors — There is substantial doubt about our ability to continue as a going concern.
  80. [80] Item 1A, Risk Factors — We have experienced negative operating cash flow and will require additional capital.
  81. [81] Item 15, Note 18 — Litigation
  82. [82] Item 1A, Risk Factors — Failure to maintain Nasdaq listing could harm us.
  83. [83] Item 1A, Risk Factors — Failure to maintain Nasdaq listing could harm us.
  84. [84] Item 1A, Risk Factors — Failure to maintain Nasdaq listing could harm us.
  85. [85] Item 1, Business — Five-Year Public Plan
  86. [86] Item 1, Business — Five-Year Public Plan
  87. [87] Item 7, MD&A — Recent Developments
  88. [88] Item 15, Note 4 — Liquidity and Going Concern
  89. [89] Item 1A, Risk Factors — Failure to maintain Nasdaq listing could harm us.
  90. [90] Item 1A, Risk Factors — Failure to maintain Nasdaq listing could harm us.
  91. [91] Item 1A, Risk Factors — Failure to maintain Nasdaq listing could harm us.

Analysis on 5/22/2026